After complicated events (cholangitis, pancreatitis), restart decisions should involve the patient's gastroenterologist and surgeon
Glycogen stores drop, and each gram of glycogen carries roughly three grams of water with it
6 Results from a systematic review and meta-analysis study showed that following discontinuation of weight management medications: Patients are estimated to return to baseline weight within 1.7 years 1,** Results from that same study also highlighted that following discontinuation of weight management medications: Cardiometabolic benefits may be lost, with markers estimated to return to baseline within 1.4 years 1,** Ongoing obesity treatment is needed for maintaining weight loss and improvements in cardiometabolic markers 4 Addressing Discontinuation Starts With Understanding What May Influence Adherence and Persistence 5 Long-term adherence is shaped by multiple, interconnected factorsand ongoing research continues to explore how challenges may interact over time
Full therapeutic effects may take 12 weeks or longer at a stable maintenance dose
According to a study published in the International Journal of Molecular Sciences [2], GHK-Cu influences multiple genes associated with antioxidant defense and cellular protection
Kelly, co-director of the University of Minnesotas Center for Pediatric Obesity Medicine